Glioblastoma (GBM) is a malignant cancer that is fatal even after standard therapy and the
effects of current available therapeutics are not promising due its complex and evolving …

Simple Summary This systematic review showed different therapeutic approaches to
glioblastoma on-a-chip with varying levels of complexity, answering, from the simplest …

Along with the introduction of innovative methods, there is a need to choose the best treat
ment suitable for an individual (ie, personalized medicine)[2]. Personalized treatment is …

Brain tumors are a widespread and serious neurological phenomenon that can be life-
threatening. The computing field has allowed for the development of artificial intelligence …

Glioblastoma bears one of the most severe prognoses of human cancers. At this time, the
available therapy is directed against specific pathological mechanisms of these tumors, as …

Glioma, a kind of central nervous system (CNS) tumor, is hard to cure and accounts for 32%
of all CNS tumors. Establishing a stable glioma model is critically important to investigate the …

Glioblastoma multiforme (GBM) is one of the most aggressive brain tumors. GBM
represents> 50% of primary tumors of the nervous system and~ 20% of intracranial …

The signalling pathways of the glioblastoma (GBM) microenvironment play critical roles in
the origin and progress of the disease. Recently, it has been shown in in silico experiments …

Background Like it happens in other tumours, glioma cells co-evolve in a microenvironment
consisting of bona fide tumour cells as well as a range of parenchymal cells, which produces …

Efficient transdisciplinary cooperation promotes the rapid discovery and clinical application
of new technologies, especially in the competitive sector of oncology. In this review, written …